1-6 of 6
Shabnam Tangri
Close
Sort by
Journal Articles

Best Practices for Validation of Measurable Residual Disease Assessments By Multiparameter Flow Cytometry in Emerging Clinical Trials of Acute Myeloid Leukemia

Pavinder Kaur, Anil Pahuja, Kevin Nguyen, Pedro Marques Ramos, PhD, Ling Du, PhD, Jacqueline J Cloos, Maaike E Heidinga, Yvonne J.M Oussoren-Brockhoff, Angele Kelder, Xun Li, Sarah Larson, MD, Shabnam Tangri, Ghanashyam Sarikonda, Naveen Dakappagari
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-137787
Published: 2020
Journal Articles

Quantitative Multiplexed Immunohistochemistry Assays for Exploring CAR Modified T Cells and Checkpoint Inhibitors in Lymphoma Trials

Thai Hong Tran, PhD, Krupa Scott, MS, Shyun-Shyun Lee, Reshma Singh, PhD, Shawn Cogan, Jennifer Bordeaux, PhD, Hummel Jennifer, MD, Jelveh Lameh, PhD, Catherine Tribouley, Sadik Kassim, Shabnam Tangri, PhD, Naveen Dakappagari, PhD
Journal: Blood
Blood (2015) 126 (23): 2659.
https://doi.org/10.1182/blood.V126.23.2659.2659
Published: 2015
Journal Articles

Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Clinical Trials & Observations
John C. Byrd, Thomas J. Kipps, Ian W. Flinn, Januaro Castro, Thomas S. Lin, William Wierda, Nyla Heerema, James Woodworth, Steve Hughes, Shabnam Tangri, Sarah Harris, Dee Wynne, Arturo Molina, Bryan Leigh, Susan O'Brien
Journal: Blood
Blood (2010) 115 (3): 489–495.
https://doi.org/10.1182/blood-2009-08-237727
Published: 2010
Journal Articles

CD80 (B7.1) Is Expressed On Both Malignant B Cells and Tumor Infiltrating T Cells in Non-Hodgkin's Lymphomas.

Shabnam Tangri, Ph.D., Naveen Dakappagari, Annalee Estrellado, Andrew P. Weng, MD, PhD, Elizabeth Holmes, M. Wayne Saville, MD, FACP, FRCPA, Kandasamy Hariharan, Steffan Ho
Journal: Blood
Blood (2009) 114 (22): 1953.
https://doi.org/10.1182/blood.V114.22.1953.1953
Published: 2009
Journal Articles

Anti-Drug Antibody Responses to Lumiliximab Are Not Detected in Relapsed Refractory CLL Patients Treated with Lumiliximab in Combination with FCR in a Phase 1/II Study

Julie Ranuio, Annalee Estrellado, Sarah Harris, Megan Shannon, Meena Subramanyam, Steve Hughes, James Woodworth, Shabnam Tangri
Journal: Blood
Blood (2008) 112 (11): 4210.
https://doi.org/10.1182/blood.V112.11.4210.4210
Published: 2008
Journal Articles

Validation of Minimal Residual Disease Flow Cytometry Method for Residual Disease Monitoring in Chronic Lymphocytic Leukemia

Shabnam Tangri, Annalee Estrellado, Julie Ranuio, Elisa Romeo, Jonathan Lawson, Lana Feng, Mike I. Nerenberg, Jonathan Diver, Sarah Harris
Journal: Blood
Blood (2008) 112 (11): 4196.
https://doi.org/10.1182/blood.V112.11.4196.4196
Published: 2008